Financial statements Apteka Verus
Balance sheet data of APTEKA VERUS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 5 985 592,56 | 6 365 095,81 | 12 912 352,82 | 10 259 450,22 | 10 284 039,79 | 11 150 718,18 |
| A. Fixed assets | 3 839 669,96 | 2 746 390,08 | 2 514 681,32 | 3 567 770,71 | 7 217 604,33 | 7 746 912,14 |
| B. Current assets | 2 145 922,60 | 3 618 705,73 | 10 397 671,50 | 6 691 679,51 | 3 066 435,46 | 3 403 806,04 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 5 985 592,56 | 6 365 095,81 | 12 912 352,82 | 10 259 450,22 | 10 284 039,79 | 11 150 718,18 |
| A. Equity | 2 265 892,04 | 2 592 816,14 | 2 972 382,71 | 4 536 197,24 | 5 556 557,37 | 6 236 453,72 |
| B. Liabilities and provisions for liabilities | 3 719 700,52 | 3 772 279,67 | 9 939 970,11 | 5 723 252,98 | 4 727 482,42 | 4 914 264,46 |
| I. Long-term liabilities | 2 299 272,89 | 2 674 783,20 | 6 713 492,52 | 3 721 534,32 | 3 560 180,77 | 3 977 909,52 |
| II. Short-term liabilities | 1 420 427,63 | 1 097 496,47 | 3 226 477,59 | 2 001 718,66 | 1 167 301,65 | 936 354,94 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.